Effect of arginine vasopressin on the canine epicardial coronary artery. Experiments on V1-receptor-mediated production of nitric oxide

Paulo Roberto B Evora, Paul J. Pearson, Alfredo J. Rodrigues, Fernanda Viaro, Hartzell V Schaff

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective -To determine whether arginine vasopressin releases endothelium-derived nitric oxide (EDNO) from the epicardial coronary artery. Methods - We studied segments of canine left circumflex coronary arteries suspended in organ chambers to measure isometric force. The coronary artery segments were contracted with prostaglandin F (2 × 10-6 M) and exposed to a unique, strong arginine vasopressin concentration (10-6 M) or titrated concentrations (10-9 a 10-5 M). Results - The unique dose of arginine vasopressin concentration (10-6 M) induced transient, but significant (p<0.05), relaxation in arterial segments with endothelium, and an increase, not significant, in tension in arteries without endothelium. Endothelium-dependent relaxation to arginine vasopressin was inhibited by Ng-monomethyl-L-arginine (L-NMMA, 10-5 M) or NG-nitro-L- arginine (L-NOARG) (10-4 M), 2 inhibitors of nitric oxide synthesis from L-arginine. Exogenous L-arginine (10-4 M), but not D-arginine (10-4 M), reversed the inhibitory effect of L-NMMA on vasopressin-mediated vasorelaxation. Endothelium dependent relaxation to vasopressin was also reversibly inhibited by the vasopressin V 1-receptor blocker d(CH2)5Try(Me) arginine vasopressin (10-6 M) (n=6, P<0.05). Conclusion - Vasopressin acts through V1 endothelial receptors to stimulate nitric oxide release from L-arginine.

Original languageEnglish (US)
Pages (from-to)489-494
Number of pages6
JournalArquivos Brasileiros de Cardiologia
Volume80
Issue number5
StatePublished - Apr 2003

Fingerprint

Vasopressin Receptors
Arginine Vasopressin
Arginine
Canidae
Coronary Vessels
Nitric Oxide
Endothelium
Vasopressins
omega-N-Methylarginine
Nitroarginine
Dinoprost
Vasodilation
Arteries

Keywords

  • Coronary artery
  • Endothelium
  • Nitric oxide
  • Vasopressin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Effect of arginine vasopressin on the canine epicardial coronary artery. Experiments on V1-receptor-mediated production of nitric oxide. / Evora, Paulo Roberto B; Pearson, Paul J.; Rodrigues, Alfredo J.; Viaro, Fernanda; Schaff, Hartzell V.

In: Arquivos Brasileiros de Cardiologia, Vol. 80, No. 5, 04.2003, p. 489-494.

Research output: Contribution to journalArticle

Evora, Paulo Roberto B ; Pearson, Paul J. ; Rodrigues, Alfredo J. ; Viaro, Fernanda ; Schaff, Hartzell V. / Effect of arginine vasopressin on the canine epicardial coronary artery. Experiments on V1-receptor-mediated production of nitric oxide. In: Arquivos Brasileiros de Cardiologia. 2003 ; Vol. 80, No. 5. pp. 489-494.
@article{f2a6fbd5fd184192aa0802081b6d268e,
title = "Effect of arginine vasopressin on the canine epicardial coronary artery. Experiments on V1-receptor-mediated production of nitric oxide",
abstract = "Objective -To determine whether arginine vasopressin releases endothelium-derived nitric oxide (EDNO) from the epicardial coronary artery. Methods - We studied segments of canine left circumflex coronary arteries suspended in organ chambers to measure isometric force. The coronary artery segments were contracted with prostaglandin F2α (2 × 10-6 M) and exposed to a unique, strong arginine vasopressin concentration (10-6 M) or titrated concentrations (10-9 a 10-5 M). Results - The unique dose of arginine vasopressin concentration (10-6 M) induced transient, but significant (p<0.05), relaxation in arterial segments with endothelium, and an increase, not significant, in tension in arteries without endothelium. Endothelium-dependent relaxation to arginine vasopressin was inhibited by Ng-monomethyl-L-arginine (L-NMMA, 10-5 M) or NG-nitro-L- arginine (L-NOARG) (10-4 M), 2 inhibitors of nitric oxide synthesis from L-arginine. Exogenous L-arginine (10-4 M), but not D-arginine (10-4 M), reversed the inhibitory effect of L-NMMA on vasopressin-mediated vasorelaxation. Endothelium dependent relaxation to vasopressin was also reversibly inhibited by the vasopressin V 1-receptor blocker d(CH2)5Try(Me) arginine vasopressin (10-6 M) (n=6, P<0.05). Conclusion - Vasopressin acts through V1 endothelial receptors to stimulate nitric oxide release from L-arginine.",
keywords = "Coronary artery, Endothelium, Nitric oxide, Vasopressin",
author = "Evora, {Paulo Roberto B} and Pearson, {Paul J.} and Rodrigues, {Alfredo J.} and Fernanda Viaro and Schaff, {Hartzell V}",
year = "2003",
month = "4",
language = "English (US)",
volume = "80",
pages = "489--494",
journal = "Arquivos Brasileiros de Cardiologia",
issn = "0066-782X",
publisher = "Arquivos Brasileiros de Cardiologia",
number = "5",

}

TY - JOUR

T1 - Effect of arginine vasopressin on the canine epicardial coronary artery. Experiments on V1-receptor-mediated production of nitric oxide

AU - Evora, Paulo Roberto B

AU - Pearson, Paul J.

AU - Rodrigues, Alfredo J.

AU - Viaro, Fernanda

AU - Schaff, Hartzell V

PY - 2003/4

Y1 - 2003/4

N2 - Objective -To determine whether arginine vasopressin releases endothelium-derived nitric oxide (EDNO) from the epicardial coronary artery. Methods - We studied segments of canine left circumflex coronary arteries suspended in organ chambers to measure isometric force. The coronary artery segments were contracted with prostaglandin F2α (2 × 10-6 M) and exposed to a unique, strong arginine vasopressin concentration (10-6 M) or titrated concentrations (10-9 a 10-5 M). Results - The unique dose of arginine vasopressin concentration (10-6 M) induced transient, but significant (p<0.05), relaxation in arterial segments with endothelium, and an increase, not significant, in tension in arteries without endothelium. Endothelium-dependent relaxation to arginine vasopressin was inhibited by Ng-monomethyl-L-arginine (L-NMMA, 10-5 M) or NG-nitro-L- arginine (L-NOARG) (10-4 M), 2 inhibitors of nitric oxide synthesis from L-arginine. Exogenous L-arginine (10-4 M), but not D-arginine (10-4 M), reversed the inhibitory effect of L-NMMA on vasopressin-mediated vasorelaxation. Endothelium dependent relaxation to vasopressin was also reversibly inhibited by the vasopressin V 1-receptor blocker d(CH2)5Try(Me) arginine vasopressin (10-6 M) (n=6, P<0.05). Conclusion - Vasopressin acts through V1 endothelial receptors to stimulate nitric oxide release from L-arginine.

AB - Objective -To determine whether arginine vasopressin releases endothelium-derived nitric oxide (EDNO) from the epicardial coronary artery. Methods - We studied segments of canine left circumflex coronary arteries suspended in organ chambers to measure isometric force. The coronary artery segments were contracted with prostaglandin F2α (2 × 10-6 M) and exposed to a unique, strong arginine vasopressin concentration (10-6 M) or titrated concentrations (10-9 a 10-5 M). Results - The unique dose of arginine vasopressin concentration (10-6 M) induced transient, but significant (p<0.05), relaxation in arterial segments with endothelium, and an increase, not significant, in tension in arteries without endothelium. Endothelium-dependent relaxation to arginine vasopressin was inhibited by Ng-monomethyl-L-arginine (L-NMMA, 10-5 M) or NG-nitro-L- arginine (L-NOARG) (10-4 M), 2 inhibitors of nitric oxide synthesis from L-arginine. Exogenous L-arginine (10-4 M), but not D-arginine (10-4 M), reversed the inhibitory effect of L-NMMA on vasopressin-mediated vasorelaxation. Endothelium dependent relaxation to vasopressin was also reversibly inhibited by the vasopressin V 1-receptor blocker d(CH2)5Try(Me) arginine vasopressin (10-6 M) (n=6, P<0.05). Conclusion - Vasopressin acts through V1 endothelial receptors to stimulate nitric oxide release from L-arginine.

KW - Coronary artery

KW - Endothelium

KW - Nitric oxide

KW - Vasopressin

UR - http://www.scopus.com/inward/record.url?scp=3343007804&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3343007804&partnerID=8YFLogxK

M3 - Article

C2 - 12792714

AN - SCOPUS:3343007804

VL - 80

SP - 489

EP - 494

JO - Arquivos Brasileiros de Cardiologia

JF - Arquivos Brasileiros de Cardiologia

SN - 0066-782X

IS - 5

ER -